相关实验视频

Updated: Jun 28, 2025

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

抑制MTH1与ROS诱导剂协同作用,触发经过帕萨纳托斯的宫癌细胞

Chunshuang Li¹, Yaoyao Xue¹, Jiaxin Wu¹

¹The Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University, Changchun, Jilin 130024, China; School of Life Sciences, Northeast Normal University, Changchun, Jilin 130024, China.

Biochimica et biophysica acta. Molecular basis of disease

|April 24, 2024

概括

通过活性氧物种 (ROS) 增加氧化应激可以诱导宫癌细胞死亡. 将ROS剂与MTH1抑制剂结合起来可以增强DNA损伤,提供更安全的化疗策略.

科学领域:

生物化学生物化学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

宫癌细胞表现出高水平的活性氧物种 (ROS),使氧化应激成为潜在的化疗点.
现有的策略面临着机制阐明,有效性和毒性方面的挑战.
8-oxo-7,8-dihydroguanine (8-oxoG) 是一个由8-oxoguanine glycosylase 1 (OGG1) 修复的关键DNA损伤.
MutT同源1 (MTH1) 通过水解8-oxo-dGTP,防止8-oxoG被纳入DNA.

研究的目的:

研究由ROS诱导剂诱导的宫癌中细胞死亡机制.
探索MTH1抑制剂与ROS诱导剂在宫癌治疗中的协同作用.
评估针对宫癌中DNA修复途径的治疗潜力.

主要方法:

在宫癌细胞中诱导氧化应激,使用ROS诱导剂.
对细胞死亡途径的评估,重点是细胞分裂和DNA损伤.
抑制MTH1并评估其与ROS剂的协同作用.
使用瘤异种移植的体内研究来评估治疗疗效.
基因操纵 (OGG1淘汰),以确认OGG1在观察到的影响中的作用.

主要成果:

诱导ROS的药物在宫癌细胞中触发了帕萨纳托斯,主要是通过OGG1-介导的8-oxoG切割的DNA链断裂.
抑制MTH1增强了DNA中的8-oxoG积累,与ROS药物协同作用.
组合疗法在体内抑制了瘤异种移植的生长.
在缺乏OGG1的模型中,瘤生长抑制显著降低,证实了OGG1的关键作用.

结论:

这项研究强调了基切除修复酶,特别是OGG1在ROS诱导的细胞死亡中的关键作用.
将较低剂量的ROS诱导剂与MTH1抑制剂相结合,为宫癌提供了潜在的更有选择性和更安全的化疗策略.
准DNA修复途径为新的宫癌治疗提供了一个有希望的途径.

关键词:

抑制了MTH1的发生.其他 OGG1 氧化性DNA损伤导致的DNA损伤.帕尔塔纳托斯 (Parthanatos) 是一个中等级的生物.产生ROS的诱导剂.

更多相关视频

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...